Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003105462 | SCV003792265 | likely pathogenic | GNE myopathy; Sialuria | 2022-08-24 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant is also known as g.24008_31495dup. A similar copy number variant has been observed in individual(s) with clinical features of autosomal recessive GNE-related myopathy (PMID: 27829678). This variant results in a copy number gain of the genomic region encompassing exon(s) 2-3 of the GNE gene. While the exact position of this variant cannot be determined from the data, sub-genic copy number gains are generally in tandem (PMID: 25640679). This variant is predicted to be out-of-frame, and may result in an absent or disrupted protein product. Loss-of-function variants in GNE are known to be pathogenic (PMID: 24027297). |